Relmada Therapeutics is a Biotech company based in New York, NY. It has raised $28M in total funding. Latest round: Growth.
Relmada Therapeutics is a Biotech company based in New York, NY. Relmada Therapeutics has raised $28M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in July 2025. The round record for Relmada Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Janus Henderson Investors, OrbiMed. 2 distinct backers are named across the disclosed rounds.
Round data for Relmada Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in New York and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026